|
Product Name |
Methyl 2-bromo-6-methoxynicotinate |
|
CAS Number |
1009735-23-2 |
|
Molecular Formula |
C8H8BrNO3 |
|
Molecular Weight |
246.06 |
|
SMILES Code |
O=C(OC)C1=C(Br)N=C(OC)C=C1 |
|
MDL No. |
MFCD18257522 |
Chemical Properties
This compound is typically obtained as a pale yellow to light brown crystalline powder. Its molecular formula is C8H8BrNO3, corresponding to a molecular weight of 246.06. The melting point generally falls within the range of 82–86°C. The calculated density is approximately 1.62 g/cm³ under ambient conditions. It is soluble in common organic solvents including dichloromethane, ethyl acetate, and tetrahydrofuran, moderately soluble in methanol and ethanol, and practically insoluble in water and nonpolar solvents such as hexane. The molecule features a pyridine ring substituted with a bromine atom at the 2position, a methoxy group at the 6position, and a methyl ester at the 3position. The ester functionality is susceptible to hydrolysis under acidic or basic conditions, while the bromine atom provides a versatile handle for transitionmetalcatalyzed crosscoupling reactions. Storage in tightly sealed containers protected from light and moisture under cool, dry conditions is recommended. Contact with strong oxidizing agents, strong acids, and strong bases should be avoided.
Description
Methyl 2-bromo-6-methoxynicotinate is a tri-substituted pyridine derivative belonging to the nicotinic acid ester family. The molecule combines three distinct functional groups: a bromine atom at the 2position, an electron-donating methoxy group at the 6position, and a methyl ester at the 3position. The pyridine core, with its electron-withdrawing nitrogen atom, provides a moderately electron-deficient aromatic platform capable of engaging in π-stacking and hydrogen bonding interactions. The bromine atom serves as a versatile electrophilic handle for palladium-catalyzed cross-coupling reactions such as Suzuki, Sonogashira, and Buchwald-Hartwig couplings, enabling the introduction of diverse aryl, heteroaryl, or amino groups. The 6methoxy substituent donates electron density through resonance, influencing both the electronic distribution and the reactivity of the ring system. The methyl ester provides a protected carboxylic acid equivalent, offering a site for further functionalization through hydrolysis, transesterification, or reduction. This combination of a modifiable halogen, an electron-donating group, and a latent carboxylic acid on a privileged heteroaromatic core makes the compound a valuable building block in medicinal chemistry and organic synthesis for constructing more complex molecules with potential biological activity.
Uses
Pharmaceutical Intermediate
In drug discovery, this brominated pyridine ester is employed as a building block for synthesizing compounds with potential activity against cancer, inflammation, and infectious diseases. The bromine atom enables late-stage diversification through cross-coupling reactions, allowing systematic exploration of structure-activity relationships. The methoxy group can influence metabolic stability and binding affinity through electronic and steric effects, while the ester can be hydrolyzed to the carboxylic acid for amide coupling with amine-containing pharmacophores. Derivatives prepared from this scaffold have been explored as kinase inhibitors and antimicrobial agents.
Building Block for Heterocyclic Systems
The compound serves as a precursor for constructing fused heterocyclic systems such as pyrido[2,3-d]pyrimidines, pyrazolo[3,4-b]pyridines, and imidazo[1,2-a]pyridines through cyclocondensation reactions. The bromine can be engaged in cross-coupling to introduce substituents that participate in ring-forming reactions, while the ester provides a handle for further functionalization. These ring systems are investigated for their pharmacological properties, with the rigid pyridine core providing conformational constraint beneficial for target recognition and selectivity.
Intermediate for Nicotinic Acid Derivatives
Hydrolysis of the ester yields 2-bromo-6-methoxynicotinic acid, a valuable building block for preparing nicotinic acid analogs with potential biological activity. These derivatives are explored for their ability to modulate lipid metabolism, act as anti-dyslipidemic agents, or serve as ligands for G-protein coupled receptors. The bromine atom enables further functionalization to optimize potency and selectivity, while the methoxy group can enhance metabolic stability compared to unsubstituted nicotinic acid.
Organic Synthesis Building Block
As a versatile synthetic intermediate, methyl 2-bromo-6-methoxynicotinate participates in diverse transformations including palladium-catalyzed cross-couplings, nucleophilic aromatic substitution (after activation), and directed metalation strategies. The bromine can be replaced with various nucleophiles or converted to organometallic species for further functionalization. The ester can be reduced to the corresponding alcohol for ether formation or converted to other functional groups. The methoxy group can be selectively demethylated under appropriate conditions to reveal a phenolic hydroxyl for additional elaboration. Its utility extends to the synthesis of natural product analogs and functional materials where the pyridine ring imparts desirable electronic and hydrogen-bonding properties.







![6-Chloro-1H-pyrazolo[3,4-b]pyridine](/uploads/44503/small/6-chloro-1h-pyrazolo-3-4-b-pyridine190bd.png?size=195x0)



